Close Menu

FNIH

Having raised $1.5 million in funding since announcing the project at a 2017 AACR meeting, the group anticipates completing the first phase of the project by Q2 2020.  

FNIH Wall

Stat News writes that the Foundation for the National Institutes of Health might not be providing the ethical barrier it is supposed to.

A US House of Representatives committee calls on the Foundation for the NIH and the CDC Foundation to be more transparent about their donors, Stat News says.

The company is testing a five-protein panel in longitudinal samples to see if it could help with early detection and prediction of progression in Alzheimer's.

NEW YORK (GenomeWeb) – The National Institutes of Health said today it has awarded $6 million to 11 research teams for studies that will use genomic and single-cell-level analyses to identify potential therapeutic and diagnostic targets for rheumatoid arthritis and lupus.

NEW YORK (GenomeWeb News) – The National Institutes of Health said today it plans to spend nearly $230 million in a partnership with 10 pharmaceutical firms and several non-profit groups to jumpstart efforts to find targets for new drugs and diagnostics.

NEW YORK (GenomeWeb News) – The Foundation for the National Institutes of Health on Thursday announced that the I-SPY 2 Trial has graduated the first two drugs from its multidrug standing platform trial.

The National Institutes of Health last month announced two funding opportunities with potential microRNA components, seeking grant proposals in the areas of acute kidney injury and the genomic basis of neurodevelopment and mental disorders.

The diagnostic is being developed using a new peptoid-based technique for detecting disease-specific antibodies that could prove broadly useful as a protein biomarker discovery tool, said a researcher.

A plasma-based biomarker test for Alzheimer's could serve as a useful initial screen for the disease, as well as provide drugmakers with a way of selecting trial subjects that could be considerably less expensive than current methods like CSF analysis and PET scans.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.